Search for Clinical Trial Results
Acute Erythroid Leukemia - 189 Studies Found
Status | Study |
Active, not recruiting |
Study Name: Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia Condition:
|
Active, not recruiting |
Study Name: Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders Condition:
|
Completed |
Study Name: Tipifarnib and Bortezomib in Treating Patients With Acute Leukemia or Chronic Myelogenous Leukemia in Blast Phase Condition:
|
Completed |
Study Name: Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia Condition:
|
Active, not recruiting |
Study Name: CPX-351 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Condition:
|
Completed |
Study Name: Vorinostat in Treating Patients With Acute Myeloid Leukemia Condition:
|
Completed |
Study Name: Choline Magnesium Trisalicylate and Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia Condition:
|
Terminated |
Study Name: AML Therapy With Irradiated Allogeneic Cells Condition:
|
Recruiting |
Study Name: Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia Condition:
|